What is the significance of foamy urine and how should it be evaluated and managed?

Foamy Urine: Clinical Significance and Management

Foamy urine warrants systematic evaluation for proteinuria, as approximately 20-30% of patients with this complaint have clinically significant proteinuria or albuminuria requiring further workup.

Initial Evaluation

First-Line Testing

Obtain a first morning void midstream urine sample for initial assessment, testing in the following order of preference 1:

• Urine albumin-to-creatinine ratio (ACR) - most preferred
• Reagent strip urinalysis for albumin with automated reading
• If measuring total protein: urine protein-to-creatinine ratio (PCR)

In children specifically, obtain both PCR and ACR from a first morning sample 1.

Confirmation of Positive Results

If initial testing shows abnormalities 1:

• Confirm any reagent strip positive results with quantitative laboratory measurement (ACR or PCR)
• Confirm ACR ≥30 mg/g (≥3 mg/mmol) on random urine with a subsequent first morning void sample
• This two-step approach accounts for biological variability and reduces false positives

Clinical Context and Risk Stratification

Among patients presenting with foamy urine 2:

• 22% have overt proteinuria (protein-to-creatinine ratio indicating nephrotic-range or significant proteinuria)
• 32% have microalbuminuria or overt proteinuria when ACR is measured
• Key risk factors for significant proteinuria include:
  • Elevated serum creatinine (strongest predictor)
  • Elevated serum phosphate
  • Diabetes mellitus
  • Reduced estimated GFR

Factors Causing False Results

Be aware of conditions that affect interpretation 1:

Falsely elevated ACR/PCR:

• Hematuria or menstruation
• Recent vigorous exercise
• Urinary tract infection
• Lower urinary creatinine in females (physiologically lower muscle mass)

Falsely decreased ACR/PCR:

• Higher urinary creatinine in males
• High body weight/muscle mass
• High protein intake

GFR Assessment

Use a validated eGFR equation rather than serum creatinine alone 1:

• Apply the CKD-EPI creatinine equation for adults
• Avoid using race in GFR computation
• In children over age 2, flag eGFR <90 ml/min per 1.73 m² as "low"
• Use the Schwartz equation or Full Age Spectrum (FAS) equation for pediatric patients 1

When to Pursue Further Workup

Proceed with nephrology evaluation if 1:

• Confirmed persistent albuminuria (ACR ≥30 mg/g on repeat testing)
• Overt proteinuria (PCR significantly elevated)
• Concurrent hematuria, especially with dysmorphic red cells or red cell casts
• Reduced eGFR
• Elevated serum creatinine or phosphate 2

Additional Urinalysis Components

Examine urine sediment for 1:

• Erythrocyte morphology (dysmorphic RBCs suggest glomerular disease)
• Red cell casts or acanthocytes (pathognomonic for glomerular disease)
• White blood cells (infection vs. inflammation)

Common Pitfalls

• Do not dismiss foamy urine as benign without objective testing—approximately 1 in 5 patients have significant proteinuria 2
• Do not rely on single random urine samples—confirm with first morning void 1
• Do not use serum creatinine alone—always calculate eGFR using validated equations 1
• Consider timing of sample collection—exercise, infection, and menstruation can cause transient proteinuria 1
• In children, use age-appropriate reference ranges and both ACR and PCR for comprehensive assessment 1

Management of Confirmed Proteinuria

If proteinuria is confirmed 1:

• Quantify the degree using 24-hour urine collection or spot urine PCR
• Target PCR <200 mg/g (<20 mg/mmol) in children with glomerular disease
• Initiate RAS blockade (ACE inhibitors or ARBs) for persistent albuminuria with appropriate blood pressure control
• Consider nephrology referral for persistent proteinuria, especially if nephrotic-range (>3.5 g/day or PCR >3500 mg/g)